QuidelOrtho Corp (QDEL)
39.63
+0.54
(+1.38%)
USD |
NASDAQ |
Nov 05, 14:41
QuidelOrtho Net Income (Annual): -10.10M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -10.10M |
December 31, 2022 | 548.70M |
December 31, 2021 | 704.20M |
December 31, 2020 | 810.29M |
December 31, 2019 | 72.92M |
December 31, 2018 | 74.18M |
December 31, 2017 | -8.165M |
December 31, 2016 | -13.81M |
December 31, 2015 | -6.079M |
December 31, 2014 | -7.074M |
December 31, 2013 | 7.39M |
December 31, 2012 | 4.993M |
December 31, 2011 | 7.633M |
December 31, 2010 | -11.27M |
December 31, 2009 | 32.88M |
December 31, 2008 | 18.85M |
December 31, 2007 | 13.63M |
December 31, 2006 | 21.72M |
December 31, 2005 | -9.259M |
December 31, 2004 | -6.287M |
December 31, 2003 | 19.65M |
Date | Value |
---|---|
December 31, 2002 | 1.291M |
December 31, 2001 | 0.192M |
December 31, 2000 | -5.846M |
December 31, 1999 | -1.50M |
March 31, 1999 | 7.70M |
March 31, 1998 | 1.10M |
March 31, 1997 | 3.50M |
March 31, 1996 | 0.60M |
March 31, 1995 | -4.10M |
March 31, 1994 | -2.00M |
March 31, 1993 | 0.70M |
March 31, 1992 | 0.80M |
March 31, 1991 | -5.50M |
March 31, 1990 | -1.20M |
March 31, 1989 | -3.10M |
March 31, 1988 | -7.30M |
March 31, 1987 | -8.10M |
March 31, 1986 | -0.10M |
March 31, 1985 | -2.90M |
March 31, 1984 | -3.60M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-10.10M
Minimum
2023
810.29M
Maximum
2020
425.20M
Average
548.70M
Median
2022
Net Income (Annual) Benchmarks
Abbott Laboratories | 5.723B |
Becton Dickinson & Co | 1.484B |
Repligen Corp | 41.58M |
Perspective Therapeutics Inc | -46.51M |
Xtant Medical Holdings Inc | 0.66M |